Cargando…
In silico mining identifies IGFBP3 as a novel target of methylation in prostate cancer
Promoter hypermethylation is central in deregulating gene expression in cancer. Identification of novel methylation targets in specific cancers provides a basis for their use as biomarkers of disease occurrence and progression. We developed an in silico strategy to globally identify potential target...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2007
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359953/ https://www.ncbi.nlm.nih.gov/pubmed/17453001 http://dx.doi.org/10.1038/sj.bjc.6603767 |